Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus.
Alkabab Y, Warkentin J, Cummins J, Katz B, Denison BM, Bartok A, Khalil A, Young LR, Timme E, Peloquin CA, Ashkin D, Houpt ER, Heysell SK. Alkabab Y, et al. Among authors: heysell sk. Int J Tuberc Lung Dis. 2023 Feb 1;27(2):135-139. doi: 10.5588/ijtld.22.0448. Int J Tuberc Lung Dis. 2023. PMID: 36853114 Free PMC article.
Omadacycline pharmacokinetics/pharmacodynamics in the hollow fiber model and clinical validation of efficacy to treat pulmonary Mycobacterium abscessus disease.
Singh S, Wang JY, Heysell SK, McShane PJ, Wadle C, Shankar P, Huang HL, Pasipanodya J, Boorgula GD, Philley JV, Gumbo T, Srivastava S. Singh S, et al. Among authors: heysell sk. Int J Antimicrob Agents. 2023 Jul;62(1):106847. doi: 10.1016/j.ijantimicag.2023.106847. Epub 2023 May 13. Int J Antimicrob Agents. 2023. PMID: 37187338 Free PMC article.
Implementing Innovative Approaches to Improve Health Care Delivery Systems for Integrating Communicable and Non-Communicable Diseases Using Tuberculosis and Diabetes as a Model in Tanzania.
Mpagama SG, Byashalira KC, Chamba NG, Heysell SK, Alimohamed MZ, Shayo PJ, Kalolo A, Chongolo AM, Gitige CG, Mmbaga BT, Ntinginya NE, Alffenaar JC, Bygbjerg IC, Lillebaek T, Christensen DL, Ramaiya KL. Mpagama SG, et al. Among authors: heysell sk. Int J Environ Res Public Health. 2023 Aug 29;20(17):6670. doi: 10.3390/ijerph20176670. Int J Environ Res Public Health. 2023. PMID: 37681810 Free PMC article.
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.
Sasson J, Donlan AN, Ma JZ, Haughey HM, Coleman R, Nayak U, Mathers AJ, Laverdure S, Dewar R, Jackson PEH, Heysell SK, Sturek JM, Petri WA Jr. Sasson J, et al. Among authors: heysell sk. medRxiv [Preprint]. 2022 May 19:2022.03.30.22273194. doi: 10.1101/2022.03.30.22273194. medRxiv. 2022. Update in: Open Forum Infect Dis. 2022 Jul 27;9(8):ofac343. doi: 10.1093/ofid/ofac343 PMID: 35411349 Free PMC article. Updated. Preprint.
Point-of-care glycated hemoglobin a1c testing for the identification of hyperglycemia severity among individuals with dual tuberculosis and diabetes mellitus in Tanzania.
Byashalira KC, Chamba NG, Alkabab Y, Ntinginya NE, Affenaar JW, Heysell SK, Ramaiya KL, Lillebaek T, Bygbjerg IC, Christensen DL, Mpagama SG, Mmbaga BT. Byashalira KC, et al. Among authors: heysell sk. Int J Mycobacteriol. 2023 Oct-Dec;12(4):429-435. doi: 10.4103/ijmy.ijmy_119_23. Int J Mycobacteriol. 2023. PMID: 38149539 Free article.
Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania.
Mpagama SG, Mvungi HC, Mbelele PM, Semvua HH, Liyoyo AA, de Guex KP, Sloan D, Kibiki GS, Boeree M, Phillips PPJ, Heysell SK. Mpagama SG, et al. Among authors: heysell sk. Pilot Feasibility Stud. 2023 Apr 1;9(1):55. doi: 10.1186/s40814-023-01281-7. Pilot Feasibility Stud. 2023. PMID: 37005695 Free PMC article.
Pharmacogenetic variability and the probability of site of action target attainment during tuberculosis meningitis treatment: A physiologically based pharmacokinetic modeling and simulations study.
Mehta K, Narayanan N, Heysell SK, Bisson GP, Subbian S, Kurepina N, Kreiswirth BN, Vinnard C. Mehta K, et al. Among authors: heysell sk. Tuberculosis (Edinb). 2022 Dec;137:102271. doi: 10.1016/j.tube.2022.102271. Epub 2022 Oct 20. Tuberculosis (Edinb). 2022. PMID: 36375279 Free article.
161 results